HEALTHglobal
Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration - GEN - Genetic Engineering and Biotechnology News
Single source
Updated 3 hours ago
First seen March 18, 2026 02:40:35Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration GEN - Genetic Engineering and Biotechnology News